{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:46:20Z","timestamp":1785818780684,"version":"3.56.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Psoriasis is a chronic immune-mediated inflammatory disease (IMID) with systemic involvement. In mild-to-moderate disease, circulating cytokines may inadequately capture systemic inflammatory burden. Composite hematological indices derived from complete blood counts, such as the systemic immune\u2013inflammation index (SII) and systemic inflammation response index (SIRI), have emerged as sensitive prognostic markers of systemic inflammation, including in psoriasis. This exploratory\n                      <jats:italic>post hoc<\/jats:italic>\n                      analysis investigated the effects of orally administered herring roe oil (HRO), a phospholipid-rich marine oil, on systemic inflammation in patients with mild-to-moderate psoriasis utilizing these biomarkers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Data were analyzed from a randomized, double-blind, placebo-controlled 26-week clinical study which investigated HRO supplementation in patients (\n                      <jats:italic>N<\/jats:italic>\n                      \u202f=\u202f64) with mild-to-moderate psoriasis (NCT03359577). SII, SIRI, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) were calculated at baseline, week 12, and week 26 for patients where baseline complete blood counts (CBCs) were available (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f60). Patients missing baseline CBCs were excluded from the analysis. Continuous changes were assessed using ANCOVA with baseline adjustment. Categorical responder analyses were performed with 25 and 30% reduction thresholds and stratification by baseline biomarker medians were performed to evaluate treatment responses and impact of baseline inflammation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with placebo, HRO treatment resulted in significant mean reductions in SII, SIRI, and PLR at week 26, with supportive trends and responder effects observed as early as week 12 compared to placebo. Patients with elevated baseline inflammatory indices showed the greatest reductions in systemic inflammation. Stratification by baseline SII further revealed enhanced clinical benefit, with statistically significant PASI50 response rates in the HRO arm at week 26 among patients with lower baseline SII.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HRO supplementation was associated with a time-dependent reduction in systemic inflammatory biomarkers in mild-to-moderate psoriasis patients. These findings support the utility of composite inflammatory indices for monitoring systemic inflammation and suggest that baseline SII may have utility in predicting treatment response and may be a useful tool for stratification in clinical trials in mild to moderate psoriasis patients. These results could also suggest platform-potential of HRO for resolution-oriented interventions across several inflammatory conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1861341","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:27:08Z","timestamp":1785817628000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Resolution of systemic inflammation in psoriasis following herring roe oil treatment: a post hoc analysis on inflammatory biomarkers in non-severe psoriatic patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Thomas A.","family":"Ringheim-Bakka","sequence":"first","affiliation":[{"name":"Arctic Bioscience AS","place":["\u00d8rsta, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhild","family":"Gammelsaeter","sequence":"additional","affiliation":[{"name":"Arctic Bioscience AS","place":["\u00d8rsta, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e5re Steinar","family":"Tveit","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Haukeland University Hospital","place":["Bergen, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s13555-021-00518-8","article-title":"Psoriasis prevalence and severity by expert elicitation","volume":"11","author":"Papp","year":"2021","journal-title":"Dermatol Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"102193","DOI":"10.1016\/j.eclinm.2023.102193","article-title":"Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019","volume":"64","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.amepre.2014.02.012","article-title":"Prevalence of psoriasis among adults in the U.S.: 2003\u20132006 and 2009\u20132010 National Health and nutrition examination surveys","volume":"47","author":"Helmick","year":"2014","journal-title":"Am J Prev Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","article-title":"The concept of psoriasis as a systemic inflammation: implications for disease management","volume":"26","author":"Reich","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1585378","DOI":"10.3389\/fimmu.2025.1585378","article-title":"Circulating CD8 T cells from patients with mild-to-moderate psoriasis are functionally impaired","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/IJGM.S495692","article-title":"Systemic immune-inflammation index: A promising, non-invasive biomarker for Crohn\u2019s disease activity and severity assessment","volume":"18","author":"Deng","year":"2025","journal-title":"Int J Gen Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/cncr.30057","article-title":"A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy","volume":"122","author":"Qi","year":"2016","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e13230","DOI":"10.1111\/eci.13230","article-title":"Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease","volume":"50","author":"Yang","year":"2020","journal-title":"Eur J Clin Investig"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/CIA.S285000","article-title":"Association between systemic immune-inflammation index and diabetic depression","volume":"16","author":"Wang","year":"2021","journal-title":"Clin Interv Aging"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00011-024-01861-0","article-title":"Association of systemic immune-inflammation index and systemic inflammation response index with chronic kidney disease: observational study of 40,937 adults","volume":"73","author":"Huang","year":"2024","journal-title":"Inflamm Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1621209","DOI":"10.3389\/fimmu.2025.1621209","article-title":"Systemic immune-inflammation index as a versatile biomarker in autoimmune disorders: insights from rheumatoid arthritis, lupus, and spondyloarthritis","volume":"16","author":"Wu","year":"2025","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13075-023-03018-6","article-title":"The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999\u20132018","volume":"25","author":"Liu","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00393-025-01751-8","article-title":"Systemic immune-inflammation index and systemic inflammation response index in systemic lupus erythematosus: a meta-analysis","volume":"85","author":"Lee","year":"2025","journal-title":"Z F\u00fcr Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"352","DOI":"10.12865\/CHSJ.46.04.05","article-title":"Systemic immune-inflammation index (SII) predicts increased severity in psoriasis and psoriatic arthritis","volume":"46","author":"Yorulmaz","year":"2020","journal-title":"Curr Health Sci J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e70050","DOI":"10.1002\/iid3.70050","article-title":"Association between systemic immune-inflammation index and psoriasis, psoriasis comorbidities, and all-cause mortality: A study based on NHANES","volume":"12","author":"Zhao","year":"2024","journal-title":"Immun Inflamm Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e37236","DOI":"10.1097\/MD.0000000000037236","article-title":"Association of systemic inflammation index with psoriasis risk and psoriasis severity: A retrospective cohort study of NHANES 2009 to 2014","volume":"103","author":"Guo","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e14101","DOI":"10.1111\/ijcp.14101","article-title":"The utility of systemic-immune inflammation index for predicting the disease activation in patients with psoriasis","volume":"75","author":"Dincer Rota","year":"2021","journal-title":"Int J Clin Pract"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1323174","DOI":"10.3389\/fimmu.2024.1323174","article-title":"Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANES","volume":"15","author":"Ma","year":"2024","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.3390\/ijms26083868","article-title":"The relationship between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index markers and response to biological therapy in patients with psoriasis","volume":"26","author":"Kimak-Pielas","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/jvc2.70001","article-title":"The systemic immune-inflammation index and its association with biologic therapy switching and response in psoriasis","volume":"4","author":"Murray","year":"2025","journal-title":"JEADV Clin Pract"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"adv00154","DOI":"10.2340\/00015555-3507","article-title":"A randomized, double-blind, placebo-controlled clinical study to investigate the efficacy of herring roe oil for treatment of psoriasis","volume":"100","author":"Tveit","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1128986","DOI":"10.3389\/fimmu.2023.1128986","article-title":"Herring roe oil in treatment of psoriasis \u2013 influence on immune cells and cytokine network","volume":"14","author":"Petrovic","year":"2023","journal-title":"Front Immunol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.plefa.2016.01.007","article-title":"Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols","volume":"111","author":"Cook","year":"2016","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/1541-4337.12510","article-title":"Marine omega-3 (n-3) phospholipids: A comprehensive review of their properties, sources, bioavailability, and relation to brain health","volume":"19","author":"Ahmmed","year":"2020","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/molecules22111964","article-title":"Phospholipids of animal and marine origin: structure, function, and anti-inflammatory properties","volume":"22","author":"Lordan","year":"2017","journal-title":"Molecules"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"113702","DOI":"10.1016\/j.colsurfb.2023.113702","article-title":"Marine phospholipid nanoliposomes: A promising therapeutic approach for inflammatory bowel disease: preparation, safety, and efficacy evaluation","volume":"234","author":"Shabana","year":"2024","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1194\/jlr.M045930","article-title":"Higher efficacy of dietary DHA provided as a phospholipid than as a triglyceride for brain DHA accretion in neonatal piglets","volume":"55","author":"Liu","year":"2014","journal-title":"J Lipid Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"108231","DOI":"10.1016\/j.jnutbio.2019.108231","article-title":"Enrichment of brain docosahexaenoic acid (DHA) is highly dependent upon the molecular carrier of dietary DHA: lysophosphatidylcholine is more efficient than either phosphatidylcholine or triacylglycerol","volume":"74","author":"Sugasini","year":"2019","journal-title":"J Nutr Biochem"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1096\/fj.201801412R","article-title":"Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer\u2019s disease","volume":"33","author":"Patrick","year":"2019","journal-title":"FASEB J"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"11263","DOI":"10.1038\/s41598-017-11766-0","article-title":"Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice","volume":"7","author":"Sugasini","year":"2017","journal-title":"Sci Rep"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/s12035-015-9228-9","article-title":"Efficient docosahexaenoic acid uptake by the brain from a structured phospholipid","volume":"53","author":"Hachem","year":"2016","journal-title":"Mol Neurobiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1476-511x-13-82","article-title":"Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults","volume":"82","author":"Bj\u00f8rndal","year":"2014","journal-title":"Lipids Health Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbi.2019.06.046","article-title":"Herring roe oil supplementation alters microglial cell gene expression and reduces peripheral inflammation after immune activation in a neonatal piglet model","volume":"81","author":"Caputo","year":"2019","journal-title":"Brain Behav Immun"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"101016","DOI":"10.1016\/j.jlr.2026.101016","article-title":"Herring roe PLs promote SPM biosynthesis in macrophages and a keratinocyte\/fibroblast coculture as a model of psoriasis","volume":"67","author":"Ringheim-Bakka","year":"2026","journal-title":"J Lipid Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2025.04.22.650092","DOI":"10.1101\/2025.04.22.650092","article-title":"Herring roe oil exerts anti-psoriatic and immunomodulatory effects on the IL-17\/23 signaling axis in macrophages, T-cells and a keratinocyte and fibroblast co-culture","author":"Mildenberger","year":"2025","journal-title":"bioRxiv"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00403-024-02994-2","article-title":"Associations of novel complete blood count-derived inflammatory markers with psoriasis: a systematic review and meta-analysis","volume":"316","author":"Liu","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.plefa.2018.03.010","article-title":"Supplementation with eicosapentaenoic acid and docosahexaenoic acid reduces high levels of circulating proinflammatory cytokines in aging adults: A randomized, controlled study","volume":"132","author":"Tan","year":"2018","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?","volume":"75","author":"Calder","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1159\/000545148","article-title":"Treatment of plaque psoriasis with Guselkumab reduces systemic inflammatory burden as measured by neutrophil\/lymphocyte ratio, platelet\/lymphocyte ratio, and monocyte\/lymphocyte ratio: A post hoc analysis of three randomised clinical trials","volume":"241","author":"Kearney","year":"2025","journal-title":"Dermatology"},{"key":"ref42","first-page":"6524","article-title":"Role of systemic immune-inflammation index (SII) in assessing clinical efficacy of TNF-\u03b1 inhibitors for rheumatoid arthritis","volume":"15","author":"Bai","year":"2023","journal-title":"Am J Transl Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1007\/s10238-023-01035-y","article-title":"Systemic immune-inflammation index predicts prognosis and responsiveness to immunotherapy in cancer patients: a systematic review and meta-analysis","volume":"23","author":"Kou","year":"2023","journal-title":"Clin Exp Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/s12872-023-03638-5","article-title":"Association of systemic immune inflammatory index with all-cause and cause-specific mortality among individuals with type 2 diabetes","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/proceedings2023091147","article-title":"Association of Omega-3 index and blood cell count-derived systemic inflammatory indexes among testicular germ cell tumor survivors","volume":"91","author":"Zekovi\u0107","year":"2024","journal-title":"PRO"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1614427","DOI":"10.3389\/fnut.2025.1614427","article-title":"Dietary Omega-3 fatty acids inversely associated with systemic inflammatory response index (SIRI): a population-based analysis of NHANES 2005\u20132018","volume":"12","author":"Liang","year":"2025","journal-title":"Front Nutr"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J Clin Invest"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"a016311","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.4049\/jimmunol.1103652","article-title":"Resolvin E2 formation and impact in inflammation-resolution","volume":"188","author":"Oh","year":"2012","journal-title":"J Immunol Baltim Md 1950"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1182\/blood.2022019145","article-title":"Infectious neutrophil deployment is regulated by resolvin D4","volume":"142","author":"Libreros","year":"2023","journal-title":"Blood"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1182\/blood.2021013422","article-title":"Resolvin T-series reduce neutrophil extracellular traps","volume":"139","author":"Chiang","year":"2022","journal-title":"Blood"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11745-013-3863-6","article-title":"Protectin DX, a double lipoxygenase product of DHA, inhibits both ROS production in human neutrophils and cyclooxygenase activities","volume":"49","author":"Liu","year":"2014","journal-title":"Lipids"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"553","DOI":"10.12865\/CHSJ.47.04.11","article-title":"New inflammatory marker associated with disease activity in rheumatoid arthritis: the systemic immune-inflammation index","volume":"47","author":"Satis","year":"2021","journal-title":"Curr Health Sci J"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.3390\/jcm12175463","article-title":"The usefulness of cellular immune inflammation markers and ultrasound evaluation in the assessment of disease activity in patients with Spondyloarthritis","volume":"12","author":"Targo\u0144ska-St\u0119pniak","year":"2023","journal-title":"J Clin Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"115","DOI":"10.14744\/nci.2023.90132","article-title":"A potential biomarker of disease activity in systemic lupus erythematosus, systemic immune-inflammation index","volume":"11","author":"Akdogan","year":"2024","journal-title":"North Clin Istanb"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JIR.S571202","article-title":"Associations of systemic inflammatory response index (SIRI) and systemic inflammatory index (SII) with cerebral atherosclerosis","volume":"19","author":"Yang","year":"2026","journal-title":"J Inflamm Res"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/JIR.S500474","article-title":"Systemic immune-inflammation index (SII) and neutrophil-to-lymphocyte ratio (NLR): A strong predictor of disease severity in large-artery atherosclerosis (LAA) stroke patients","volume":"18","author":"Liu","year":"2025","journal-title":"J Inflamm Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1861341\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:27:10Z","timestamp":1785817630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1861341\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":58,"alternative-id":["10.3389\/fmed.2026.1861341"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1861341","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"article-number":"1861341"}}